Related Experiment Video

Updated: May 15, 2026

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Ligand-based Pharmacophore Modeling; Atom-based 3D-QSAR Analysis and Molecular Docking Studies of

P Kirubakaran1, K Muthusamy, K H D Singh

  • 1Department of Bioinformatics, Science Block, Alagappa University, Karaikudi-630 004, India.

Indian Journal of Pharmaceutical Sciences
|January 18, 2013
PubMed

Insights

Researchers developed a predictive model for phosphoinositide-dependent kinase-1 (PDK1) inhibitors, crucial for cancer therapy. This computational approach aids in designing new drugs targeting PDK1 signaling in various cancers.

Area of Science:

  • Medicinal Chemistry
  • Computational Chemistry
  • Oncology

Background:

  • Phosphoinositide-dependent kinase-1 (PDK1) is a key regulator in the PI3-kinase pathway, implicated in cell growth and proliferation.
  • Overstimulation of PDK1 signaling is observed in common human cancers, making it a significant therapeutic target.
  • Developing novel PDK1 inhibitors is critical for advancing cancer treatment strategies.

Purpose of the Study:

  • To develop a predictive computational model for phosphoinositide-dependent kinase-1 (PDK1) inhibitors.
  • To identify key pharmacophoric features essential for PDK1 inhibition.
  • To guide the design of novel, potent PDK1-targeting anticancer agents.

Main Methods:

  • Ligand-based pharmacophore modeling and 3D-quantitative structure-activity relationship (3D-QSAR) studies were performed on 82 PDK1 inhibitors.
  • A six-point pharmacophore model (2H-bond acceptors, 3H-bond donors, 1 hydrophobic group) was generated.
  • Molecular docking simulations were used to analyze inhibitor binding interactions within the PDK1 active site.

Main Results:

  • A robust 3D-QSAR model was established with high statistical significance (R(2) = 0.9557, Q(2) ext = 0.7510).
  • The model demonstrated excellent predictive power, validated by external correlation (Pearson-R = 0.8676) and predictive values (0.99, 0.88).
  • Docking studies revealed specific binding interactions of inhibitors with key PDK1 residues (Ala162, Thr222, Glu209, Glu166).

Conclusions:

  • The developed pharmacophore and 3D-QSAR model provide a reliable framework for designing novel PDK1 inhibitors.
  • Computational insights into binding interactions are crucial for molecular recognition and drug design approaches.
  • This study offers a valuable tool for the rational design of targeted cancer therapies focusing on PDK1.
Keywords:
3D-QSARExternal validationPDK1PHASEmolecular docking and prime MM-GBSA

More Related Videos

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

A Liposome Membrane Permeability Assay for Investigating the Effects of Phosphatidylinositol Phosphate Groups on Membranotropic Action of Venom PLA210:31

A Liposome Membrane Permeability Assay for Investigating the Effects of Phosphatidylinositol Phosphate Groups on Membranotropic Action of Venom PLA2

Published on: September 26, 2025

Related Concept Videos

Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...